ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 144 filers reported holding ENANTA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $13,000 | -55.2% | 582 | -40.2% | 0.00% | -66.7% |
| Q1 2016 | $29,000 | -9.4% | 973 | 0.0% | 0.00% | -25.0% |
| Q4 2015 | $32,000 | -8.6% | 973 | 0.0% | 0.00% | -20.0% |
| Q3 2015 | $35,000 | +94.4% | 973 | +148.8% | 0.01% | +150.0% |
| Q2 2015 | $18,000 | +50.0% | 391 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $12,000 | – | 391 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 519,035 | $60,156,000 | 15.36% |
| Matarin Capital Management, LLC | 201,703 | $23,377,378,000 | 1.69% |
| ARMISTICE CAPITAL, LLC | 124,000 | $14,372,000 | 0.94% |
| Sapphire Star Partners LP | 7,803 | $904,000 | 0.93% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 98,631 | $11,431,000 | 0.83% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,075,000 | $124,593,000 | 0.77% |
| Granahan Investment Management | 100,670 | $11,668,000 | 0.70% |
| Virtus ETF Advisers LLC | 6,577 | $762,000 | 0.67% |
| AlphaMark Advisors, LLC | 11,115 | $1,288,000 | 0.52% |
| Ativo Capital Management LLC | 15,029 | $1,742,000 | 0.48% |